Skip to main content

Table 1 Study outcome measures and corresponding questionnaires

From: Light therapy as a treatment of cancer-related fatigue in (non-)Hodgkin lymphoma survivors (SPARKLE trial): study protocol of a multicenter randomized controlled trial

Variable

Questionnaire

Number/type of items

Time frame

Score range

Psychometric details

Primary outcomes

 Cancer related fatigue

MFI [41]

20 four-point Likert scale

Past few days

Subscale scores: 4–20; higher scores indicate more fatigue

Subscales: general fatigue, mental fatigue, physical fatigue, reduced motivation, reduced activity. Cronbach’s alpha: 0.84

VAS-scale [42]

1 eleven-point Likert scale

This moment

0–10; higher scores indicate more fatigue

 

 Restrictions caused by fatigue

WSAS [43, 70]

5 nine-point Likert scale

Influence of fatigue on daily life

0–40; higher scores indicate higher levels of disability

Cronbach’s alpha: > 0 .79

Secondary outcomes

 Sleep quality

PSQI [44]

19 four-point Likert scale and open-ended questions

Past month

Total score: 0–21

Subscale scores: 0–3; higher scores indicate more acute sleep disturbances

Subscales: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, daytime dysfunction.

Cronbach’s alpha: 0.83

 Depression

CES-D [46, 71]

20 four-point Likert scale

Past week

0–60; higher scores indicate greater depressive symptoms

Cronbach’s alpha: 0.85–0.90

 Anxiety

STAI-6 [47]

6 four-point Likert scale

This moment

20–80; higher scores indicate increased anxiety

Cronbach’s alpha: 0.83

 Quality of life

SF-36 [48, 72]

36 Dichotomous three to six-point Likert scale

Past 4 weeks

Subscale scores: 0–100; higher scores indicates higher levels of functioning/well-being

Subscales: physical functioning, role limitations due to physical health problems, bodily pain, social functioning, general mental health, role limitations due to emotional problems, vitality, general health perceptions

Cronbach’s alpha: 0.84

 Cognitive complaints

MOS-CF6 [49, 73]

6 six-point Likert scale

Past week

0–100; higher scores indicated better cognitive functioning

Cronbach’s alpha: ≥ 0.89

 

MDASI [50]

8 eleven-point Likert scale

Past 24 h

0–80; higher score indicates worse or more disturbing cognitive complaints

 

 Cancer worries

CWS [54]

8 + 1 four-point Likert scale

Past week

9–36; higher score indicates more frequent worries about cancer

Cronbach’s alpha: 0.87

 Fatigue catastrophizing

FCS [55, 74]

10 five-point Likert scale

Current attitude

10–40; higher score indicates more catastrophizing

Cronbach’s alpha: 0.85

 Self-efficacy

SES-28 [56, 75]

7 four-point Likert scale

Current attitude

7–28; higher score indicates higher level of perceived control over fatigue symptoms

Cronbach’s alpha: 0.68–0.77

  1. CES-D Center for Epidemiological Studies – Depression scale, CWS Cancer Worry Scale, FCS Fatigue catastrophizing Scale, MDASI MD Anderson Symptom Inventory, MFI Multidimensional Fatigue Inventory, MOS-CF6 Medical Outcomes Studies Cognitive functioning, PSQI Pittsburgh Sleep Quality Index, SF-36 Medical Outcome Studies short form, SES-28 Self-efficacy Scale 28, STAI-6 State Trait Anxiety Inventory-6 items, VAS Visual Analogue Scale, WSAS Work and Social Adjustment Scale